2018 Advanced Heart Failure & Transplant Cardiology - Board Certification Review Course

Advanced Heart Failure & Transplant Cardiology - Board Certification Review Course is organized by Heart Failure Society of America (HFSA) and will be held from Aug 17 - 19, 2018 at Northwestern Medicine Prentice Women's Hospital, Chicago, Illinois, United States of America.

The target audience for this medical event is Cardiologists. This CME Conference has been approved for a maximum of 20 AMA PRA Category 1 Credits.

This HFSA Board Review Course has been designed based on the competencies identified with practice in the area of Advanced Heart Failure and Transplant Cardiology. These competencies include epidemiology, causes and management of patients with HF, management of hospitalized patients, management of comorbidities, cardiac surgery in HF, medical management of the heart transplant patient and patients with mechanical circulatory support, and evaluation and management of patients with pulmonary arterial hypertension.

Course Objectives:
Upon completion of the activity, participants will demonstrate improved competence and ability to:

For the Certification Examination in Advanced Heart Failure and Transplant Cardiology:
• Identify gaps in knowledge about advanced heart failure and transplant cardiology
• Focus study efforts on filling identified knowledge gaps
• Practice for the certification examination with ABIM-style multiple-choice test questions

For Clinical Practice:
• Describe the epidemiology of heart failure, including environmental factors, and implement strategies for the prevention of heart failure
• Describe the pathophysiology of heart failure, including normal physiology and compensatory and maladaptive mechanisms
• Assess and follow the patient with acute or advanced heart failure, using non-invasive and invasive tests and biomarkers.
• Implement guideline-based therapy for patients with chronic heart failure, including pharmacologic agents; non-pharmacologic options, such as diet and exercise; and implantable devices
• Implement appropriate care strategies for patients undergoing chemotherapy or with pulmonary hypertension, heart failure with preserved ejection fraction, or cardiorenal syndrome.
• Manage comorbidities in patients with chronic heart failure, including sleep-disordered breathing, anemia, and depression
• Implement strategies for effective disease management of the patient with advanced heart failure, including palliative care and transition to outpatient care
• Provide peri-operative management of heart failure patients undergoing cardiac transplantation or implantation of a mechanical circulatory device Concise presentations by national experts will focus on blueprint content and will be augmented by board-review-type questions posed using an audience-response system.

Additional details will be posted as soon as they are available.